KRASNIY OKTYABR INC. USA. of BROOKLYN, NY, is recalling its “ARAL SILVER VOBLA” brand “ARAL”, because the product was found to be uneviscerated.
Similar Posts
Rhino 7S Type F3 7000 contains hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use Rhino 7S Type F3 7000, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores.Early Alert: Microbore Extension Set Issue from B. Braun Medical Inc.
This communication is part of the Communications Pilot to Enhance the Medical Device Recall ProgramAQ USA Inc., d.b.a Ross Healthcare Inc. – 719517 – 02/12/2026
CGMP/Finished Pharmaceuticals/AdulteratedOngoing | Cancer Accelerated Approvals
This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications that have postmarketing requirement(s) for ongoing clinical trial(s) to verify clinical benefit.Central Admixture Pharmacy Services Inc. Phoenix, AZ. 483 issued 09/05/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 09/05/2025
Short Title (70 char) Central Admixture Pharmacy Services Inc. Phoenix, AZ. 483 issued 09/05/2025
FEI Number 3014307835
Firm Name Central Admixture Pharmacy Services Inc
Record Type 483
State AZ
EstabGeneric Drug Research Priorities & Projects
In accordance with the Generic Drug User Fee Amendments (GDUFA), FDA consults with industry and the public to create an annual list of regulatory science initiatives on generic drugs. These priorities are discussed and developed in public meetings and workshops, resulting in several awarded projects
